Volitionrx (VNRX) Change in Accured Expenses (2011 - 2025)
Volitionrx (VNRX) posted Change in Accured Expenses of -$726215.0 for Q4 2025, down 173.13% on a QoQ basis from $993076.0 in Q3 2025, and up 9.29% year-over-year from -$664460.8 in Q4 2024.
Volitionrx (VNRX) Change in Accured Expenses (2011 - 2025) Analysis & Trends
Volitionrx's Change in Accured Expenses history runs 15 years deep, the most recent figure standing at -$726215.0 for Q4 2025.
- Quarterly Change in Accured Expenses rose 9.29% year-over-year to -$726215.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $77977.0 (up 106.41% YoY) and the FY2025 annual result came in at $77977.0, up 106.41% from the prior year.
- Change in Accured Expenses was -$726215.0 for Q4 2025 at Volitionrx, down from $993076.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.2 million in Q4 2023 and bottomed at -$949636.0 in Q3 2023.
- A 5-year average of $57826.9 and a median of -$14238.5 in 2022 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2021 — Change in Accured Expenses slumped 643.52% — and 2023, when it surged 36151.57%.
- Volitionrx's Change in Accured Expenses stood at $549403.0 in 2021, then tumbled by 99.39% to $3345.0 in 2022, then jumped by 36151.57% to $1.2 million in 2023, then plunged by 166.02% to -$800624.0 in 2024, then gained by 9.29% to -$726215.0 in 2025.
- Business Quant data shows VNRX's Change in Accured Expenses at -$726215.0 in Q4 2025, $993076.0 in Q3 2025, and -$560926.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.33 Bn | 174.04 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.11 Bn | 125.23 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 107.76 Bn | 98.54 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 67.95 Bn | 66.50 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 28.43 Bn | 26.14 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Dexcom | 28.31 Bn | 27.20 Bn | 750.30 Mn | 145.10 Mn |
| 8 | Smith & Nephew | 26.77 Bn | 26.19 Bn | - | - |
| 9 | Koninklijke Philips | 25.33 Bn | 22.21 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Volitionrx | 97,064.32 | -1.02 Mn | - | -726,215.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -726,215.00 |
| Dec 31, 2025 | -726,215.00 |
| Sep 30, 2025 | 993,076.00 |
| Sep 30, 2025 | 993,076.00 |
| Jun 30, 2025 | -560,926.00 |
| Jun 30, 2025 | -560,926.00 |
| Mar 31, 2025 | 372,042.00 |
| Mar 31, 2025 | 372,042.00 |
| Dec 31, 2024 | -800,624.00 |
| Dec 31, 2024 | -800,624.00 |
| Sep 30, 2024 | -31,822.00 |
| Sep 30, 2024 | -31,822.00 |
| Jun 30, 2024 | -396,322.00 |
| Jun 30, 2024 | -396,322.00 |
| Mar 31, 2024 | 11,755.00 |
| Mar 31, 2024 | 11,755.00 |
| Dec 31, 2023 | 1.21 Mn |
| Dec 31, 2023 | 1.21 Mn |
| Sep 30, 2023 | -949,636.00 |
| Sep 30, 2023 | -949,636.00 |